Searched for
VALSARTAN
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...- Biocon unit gets USFDA nod for generic drugBiocon Pharma has received approval of its ANDA for Sacubitril/Valsartan Tablets, in 24 mg/26 mg, 49 mg/51 mg and 97 mg/103 mg strengths, f...
- Zydus Lifesciences gets USFDA nod to market chronic heart failure treatment drugZydus Lifesciences Ltd has received final approval from the USFDA to market its generic Sacubitril and Valsartan tablets for treating chron...
- Novartis heart drug price may fall by 60% on generic rollouts"At least 30-40 generic brands are expected to hit the market next in a couple of weeks," said Hari Natarajan, managing director, Pronto Co...
- HC reserves order on Natco's plea over patent for Novartis drugNatco has argued before Justice C Hari Shankar against the grant of patent by IPO to the pharmaceutical composition comprising combination ...
- JB Pharma cuts price of its top-selling heart failure drug Azmarda by 50%After the price reduction, Azmarda 50 mg will be available at Rs 39.6 per tablet as compared to Rs 78 per tablet. Azmarda is one of the top...
- Dr Reddy's launches drug to treat high blood pressure, heart failure in US marketCiting IQVIA Health data, the company said the Diovan brand and generic market had US sales of approximately USD 150 million for the most r...
- Delhi HC restrains generic pharma firms from making, selling patent drug of NovartisThe plea said the plaintiff through a press release of January 28, 2019 issued by the defendant came to know about its act in launching a p...
- Fourth carcinogen discovered in heart pills used by millionsDMF, as the solvent is known, is classified by the World Health Organization as a probable carcinogen.
- Swarms of bugs, missing data plague firms now making heart drugLast month, the FDA posted a list of 43 versions of valsartan and similar drugs that don’t contain carcinogens.
- Aurobindo Pharma USA recalls 80 lots of blood pressure drug from AmericaTo date, Aurobindo Pharma USA Inc has not received any reports of adverse events related to this recall, the release said.
- India launches probe as Chinese company recalls BP drugValsartan is used to treat patients with high blood pressure in order to reduce complications such as heart attack and stroke. Both the imp...
- Lupin launches generic hypertension drug in USLupin's tablets for treating hypertension, Amlodipine and Valsartan, are the generic version of Novartis's Exforge tablets.
- Jubilant Life Sciences shares soar nearly 12 per centJubilant Life's stock soared 10.36 per cent to settle at Rs 159.85 on the BSE. In intra-day session, it advanced by 12.77 per cent to Rs 16...
- Aurobindo Pharma rallies nearly 3% on USFDA nod for hypertension drugAt 09:40 a.m.; Aurobindo Pharma was trading 1.7 per cent higher at Rs 1107. It hit a low of Rs 1102.20 and a high of Rs 1118.50 in trade to...
- Jubilant gets USFDA nod for generic anti-hypertensive tabletsThe drug firm has received final approval from the US health regulator for Valsartan tablets and plans to launch the product immediately.
- Drug major Ranbaxy beats expectations, posts first profit in 6 quartersStock rose 6.11% to Rs 634.10 on the BSE on and also triggered a 4.31% rise in Sun Pharma, which is acquiring Ranbaxy in an all-stock deal ...
- Ranbaxy gets FDA nod to sell generic Diovan tablets in USRanbaxy Laboratories, which has been facing regulatory hurdles in the US, has been allowed to sell generic Valsartan tablets.
- Lupin gets USFDA nod for generic hypertension drugLupin today said it has received US health regulator's approval to market generic version of Novartis Pharmaceuticals Corp's Diovan HCT Tab...
- Ranbaxy gets USFDA nod for Valsartan tabletsRanbaxy Laboratories has received tentative approval from the US Food and Drug Administration to manufacture and market valsartan tablets, ...
Load More
